➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Harvard Business School
McKinsey
AstraZeneca
Baxter

Last Updated: June 24, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Sulfatinib


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Sulfatinib?

Sulfatinib is an investigational drug.

There have been 14 clinical trials for Sulfatinib. The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2015.

The most common disease conditions in clinical trials are Neuroendocrine Tumors, Carcinoid Tumor, and Thyroid Neoplasms. The leading clinical trial sponsors are Hutchison Medipharma Limited, BeiGene, and Fudan University.

There are four US patents protecting this investigational drug and twenty-five international patents.

Recent Clinical Trials for Sulfatinib
TitleSponsorPhase
Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid TumorsBeiGenePhase 1/Phase 2
Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid TumorsHutchison Medipharma LimitedPhase 1/Phase 2
Open-Label Surufatinib in European Patients With NETHutchison Medipharma LimitedPhase 2

See all Sulfatinib clinical trials

Clinical Trial Summary for Sulfatinib

Top disease conditions for Sulfatinib
Top clinical trial sponsors for Sulfatinib

See all Sulfatinib clinical trials

US Patents for Sulfatinib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Sulfatinib   Try Before You Buy Stable, concentrated radionuclide complex solutions ADVANCED ACCELERATOR APPLICATIONS (ITALY) S.R.L. (Pozzilli (Isernia), IT)   Try Before You Buy
Sulfatinib   Try Before You Buy Stable, concentrated radionuclide complex solutions ADVANCED ACCELERATOR APPLICATIONS (ITALY) S.R.L. (Pozzilli (Isernia), IT)   Try Before You Buy
Sulfatinib   Try Before You Buy Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use Hutchison MediPharma Limited (Shanghai, CN)   Try Before You Buy
Sulfatinib   Try Before You Buy Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use Hutchison Medipharma Limited (Shanghai, CN)   Try Before You Buy
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Sulfatinib

Drugname Country Document Number Estimated Expiration Related US Patent
Sulfatinib Taiwan TW202019489 2038-07-25   Try Before You Buy
Sulfatinib World Intellectual Property Organization (WIPO) WO2020021310 2038-07-25   Try Before You Buy
Sulfatinib World Intellectual Property Organization (WIPO) WO2020021322 2038-07-25   Try Before You Buy
Sulfatinib World Intellectual Property Organization (WIPO) WO2020021465 2038-07-25   Try Before You Buy
Sulfatinib World Intellectual Property Organization (WIPO) WO2020064693 2038-07-25   Try Before You Buy
Sulfatinib Taiwan TW202019489 2038-07-25   Try Before You Buy
Sulfatinib World Intellectual Property Organization (WIPO) WO2020021310 2038-07-25   Try Before You Buy
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Baxter
Express Scripts
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.